The Journal Article Peer reviewed by over 70 Doctors and research analysis is enough evidence to convince anybody of average intelligence that DCVAX extends the life of many over the SOC.
Optune's TTF device has never extended life and more importantly it reduces the quality of life during the few precious remaining months of life. I as many others on this board have witnessed this first hand. You simply don't know what your talking about.
Wait a minute. Did NVCR just recruit 10 new patients over the whole third quarter? Did CEO, CTO dump their shares like crazy? The fact that patients are willing to suffer tremendou inconvenience and have to wear the metal helmet over 18 hours each day shows there is huge unmet need in GBM treatment. DCVax-L fits that need perfectly.
Market Data 
Markets 
AI
